Finasteride tablets recalled for manufacturing practice deviations
Accord Healthcare recalls 325,356 bottles of Finasteride 1 mg tablets due to manufacturing practice deviations identified during an FDA inspection. Affected batches were distributed in the United States, Puerto Rico, and Canada.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II FDA recall with no reported illnesses or injuries. The recall addresses manufacturing practice deviations discovered during inspection rather than a specific identified contamination or product defect with documented harm. Per the rubric, recalls with no reported illnesses score at most 3; the manufacturing quality control nature supports a Moderate (2) rating.
Plain-English summary
Accord Healthcare, Inc. is recalling Finasteride (finasteride) 1 mg tablets due to Current Good Manufacturing Practice (CGMP) deviations discovered during an FDA inspection.
The recall affects 325,356 bottles distributed across the United States, including Puerto Rico and Canada. Affected packages include 30-count and 90-count bottles with specific batch numbers and expiration dates: P2005979 (10/31/2023), P2100252 (12/31/2023), P2101710 (2/29/2024), P2100253 (12/31/2023), P2103035 (4/30/2024), and P2103036 (4/30/2024).
Consumers who have purchased affected Finasteride tablets should contact Accord Healthcare or their healthcare provider with questions about the recall.
The recalled product
- Product
- FINASTERIDE (FINASTERIDE)
- Brand
- FINASTERIDE
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug
- Hazard
- Affected units
- 325,356
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Batches: a) P2005979
- Exp. Date 10/31/2023
- P2100252
- Exp. Date 12/31/2023
- P2101710
- Exp. Date 2/29/2024
- b) P2100253
- P2103035
- Exp. Date 4/30/2024
- P2103036
UPCs (3)
- 0316729089104
- 316729089104
- 316729089159
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 67 recalled by Accord Healthcare, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 67 products in this recall →Related recalls
Same brand · FINASTERIDE
- ModerateFinasteride 5 mg Tablets Recalled Due to Manufacturing Process Deviations
FDA (Drugs) · 2023-03-08
- LowFinasteride Tablets Recalled for Excessive Thickness in Specific Lot
FDA (Drugs) · 2017-02-08
Same manufacturer · Accord Healthcare, Inc.
See all →- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19